HCPro, JustCoding Outpatient - 2021 Issue 42 (October)
Q&A: ICD-10-CM coding for breast implant-associated ALCL
October 19th, 2021
Subscribe or sign in to view the full article.
Article Overview
This article reviews a coding question about breast implant-associated anaplastic large cell lymphoma and summarizes the ICD-10-CM guidance discussed in the 2022 update. It is intended for coders and compliance professionals who need to understand the topic, the relevant diagnosis coding context, and the broader reporting considerations associated with this condition. The piece focuses on the relationship between the condition, implant status documentation, and the official guideline update without substituting for the full premium guidance.
Why This Topic Matters
BIA-ALCL is a specialized diagnosis with updated ICD-10-CM guidance, so accurate code selection and related documentation are important for compliant reporting and record capture.
Article Sections
-
Q&A: ICD-10-CM coding for breast implant-associated ALCL
An introductory coding question about how the condition is classified in ICD-10-CM and how it relates to other lymphoma coding concepts.
-
2022 ICD-10-CM update and official guidance
A summary of the update discussed in the article and the related official coding guidance for reporting this condition.
-
Editor’s note
Source attribution for the expert response and the webinar context in which the guidance was discussed.
What You Will Learn
- How the article frames breast implant-associated anaplastic large cell lymphoma within ICD-10-CM guidance
- What general type of coding update is discussed
- Why implant-related documentation is part of the reporting context
- Which official guidance source is referenced in the discussion
Who Should Read This
- Medical coders
- Coding educators
- Compliance staff
- Revenue cycle professionals
- Clinical documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com